Long-term safety and efficacy of the anti-MAdCAM monoclonal antibody SHP647 for the treatment of Crohn's disease: The OPERA II study

Authors
Category Primary study
JournalJournal of Crohn's and Colitis
Year 2018
This article has no abstract
Epistemonikos ID: b084dad93b12dab70dc4bb5f672f21197e695140
First added on: Feb 09, 2025